Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), announced today that its President and Chief Executive Officer, Christopher J. Schaber, Ph.D., will deliver a corporate presentation at the BIO Investor Forum, held virtually October 13-15, 2020.
October 8, 2020
· 4 min read